India Business Excellence Fund III Trims Stake in Molbio Diagnostics to 8.92%
Molbio Diagnostics Ltd 路 Acquisition/ Disposal of Shares 路 25 Sept 2026, 6:44 pm
India Business Excellence Fund III Trims Stake in Molbio Diagnostics to 8.92% India Business Excellence Fund III sold 30,00,000 equity shares (2.60% stake) of Molbio Diagnostics Limited via the open market on 23rd Sep'26. Following the transaction, the fund's shareholding decreased from 1,32,76,750 shares (11.52%) to 1,02,76,750 shares (8.92% of total voting capital). The disposal triggered SEBI SAST Regulation 29(2) reporting requirements by breaching the 2% threshold limit. Total paid-up equity share capital of Molbio Diagnostics remains unchanged at 11,52,39,996 shares of INR 1 face value each.
Original exchange filing (PDF)
More announcements from Molbio Diagnostics Ltd
- Transcript of Earnings Call with analysts and investors for the quarter and half year ended on September 30, 2026 路 11 Nov 2026
- Monitoring Agency Report on the utilization of proceeds raised through issuance of equity shares by way of Public Issue of the Company 路 07 Nov 2026
- Audio Recording of Earnings call held on November 05,2026 for the quarter and half year ended September 30,2026. 路 06 Nov 2026
- Outcome of Board meeting held on Thursday, November 05, 2026 路 06 Nov 2026
- Investor presentation 路 05 Nov 2026
- Outcome of the Board Meeting 路 05 Nov 2026
- Molbio Diagnostics Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Intimation of Earnings Conference Call on November 05, 2026, at 05:30 P.M. IST to discuss the financial performance of the Company for the quarter and half year ended September 30, 2026. 路 05 Nov 2026
